Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Key

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Transactions of the American Clinical and Climatological Association|January 1, 1992
Herpes virus infection of endothelium: new insights into atherosclerosisH S Jacob, M Visser, N S Key, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2004
Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitorA A Ashrani, M T Reding, A Shet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2018
DDAVP trial in discrepant non-severe haemophilia A patientsH C Okoye, B I Nielsen, K Lee, et al.
Lancet (London, England)|November 7, 1987
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemiaN S Key, P M Kelly, P M Emerson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytesC Marsik, G Endler, T Halama, et al.
Thrombosis Research|July 15, 1992
Prothrombotic phenotype diversity of human aortic endothelial cells in cultureA S Antonov, N S Key, M D Smirnov, et al.
Bone Marrow Transplantation|November 30, 2006
Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapyA A Ashrani, D A Gabriel, J L Gajewski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 4, 2014
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiencyF Nuzzo, C Bulato, B I Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolismL M Reich, A R Folsom, N S Key, et al.
Thrombosis and Haemostasis|March 15, 2001
Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantationM Ozcan, C T Morton, A Solovey, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Transactions of the American Clinical and Climatological Association|January 1, 1992
Herpes virus infection of endothelium: new insights into atherosclerosisH S Jacob, M Visser, N S Key, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 1, 2004
Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitorA A Ashrani, M T Reding, A Shet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2018
DDAVP trial in discrepant non-severe haemophilia A patientsH C Okoye, B I Nielsen, K Lee, et al.
Lancet (London, England)|November 7, 1987
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemiaN S Key, P M Kelly, P M Emerson, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytesC Marsik, G Endler, T Halama, et al.
Thrombosis Research|July 15, 1992
Prothrombotic phenotype diversity of human aortic endothelial cells in cultureA S Antonov, N S Key, M D Smirnov, et al.
Bone Marrow Transplantation|November 30, 2006
Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapyA A Ashrani, D A Gabriel, J L Gajewski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 4, 2014
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiencyF Nuzzo, C Bulato, B I Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolismL M Reich, A R Folsom, N S Key, et al.
Thrombosis and Haemostasis|March 15, 2001
Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantationM Ozcan, C T Morton, A Solovey, et al.
Pageof 9